Latest News

Many of the greatest stocks have fallen sharply in the past -- and then recovered.

Alphabet is looking to be a big winner in artificial intelligence, defying skeptics.

T-Mobile stock is rallying after the company reported a new set of industry-leading KPIs, and financial strength continues to endure and expand.

This innovative financial services enterprise is pushing further into uncharted waters.

Some of these developments could improve the company's prospects.

Crypto-related stocks and ETFs, such as IBIT, MSTR, COIN, BMNR, and ETHA, are gaining momentum as investors seek exposure to the crypto momentum.

I got a $1,000 investment bonus from work. Instead of chasing hot stocks for a quick win, I'm aiming for long-term growth with boring index funds.

These companies are all pushing AI research forward in their respective fields.

Results start in early August as investors eye revenue growth amid losses.

The Texas-based space and defense technology startup aims to raise nearly $632 million in funds through its IPO.

Tesla rival Xiaomi has a new entry. A U.S.-China trade truce reportedly will be extended.

Markets are pricing in a roughly 75% chance that the Reserve Bank of New Zealand will cut its benchmark rate from 3.25% by 25 basis points at its August meeting.

These big pharma stocks arguably aren't receiving the respect they deserve.

HealthEquity (HQY) shows strong growth fundamentals and a promising technical setup, making it a potential breakout stock for investors seeking momentum and earnings growth.

Microsoft (MSFT) is a top dividend stock with strong growth, solid profitability, and financial health, making it ideal for long-term investors.

Energy Transfer and Enterprise Products Partners are both reliable income investments.

US President Trump threatened on 14th July that if a Russia-Ukraine peace agreement didn’t happen within 50 days, then very high secondary tariffs would be imposed on Russia’s trading partners.

Life sciences company Revvity (NYSE:RVTY) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.1% year on year to $720.3 million. The company expects the full year’s revenue to be around $2.86 billion, close to analysts’ estimates. Its non-GAAP profit of $1.18 per share was 3.4% above analysts’ consensus estimates.

Celestica Inc (CLS) offers a strong growth and technical breakout setup, with robust earnings, revenue growth, and bullish momentum, making it a top pick for investors.

Expert highlights the top high divided yielding stocks and funds that investors could consider to seize the opportunity amid high Fed rates.